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Introduction and aims – Particles of titanium dioxide
(TiO2) with typical size below 100 nm have gained a broad
range of application by now, partly involving direct human
exposure. Their known properties – high specific surface,
mobility within the organism, induction of oxidative stress,
release of inflammation mediators etc. – raise the possibility
of nervous system damage but the available data regarding
this are scarce and contradictory. Based on that, and the
experiences with other metal oxide nanoparticles, the aim of
the present study was to investigate certain general end ner-
vous system toxic effects of TiO2 nanoparticles applied in
the airways of rats.
Materials and methods – Young adult Wistar rats (5 
groups of 10 rats each) received, daily for 28 days, intratra-
cheal instillations of titanium dioxide nanoparticles of ca. 10
nm diameter, suspended in 1% hydroxyethyl cellulose dissol-
ved in phosphate-buffered saline, in the doses of 1, 3, and
10 mg/kg b. w. Vehicle controls received the suspension
medium and there was also an untreated control group.
During treatment, the rats’ body weight was measured, and
their clinical state observed, daily. After the 28 days, sponta-
neous cortical activity, sensory evoked potentials and tail
nerve action potential was recorded in urethane anesthesia,
then the rats were dissected and tissue samples were taken
for Ti level determination and biochemical measurements of
some oxidative stress indicators.
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Bevezetés és célkitûzés – A titán-dioxid (TiO2)
nanoméretû, jellemzôen 100 nm-nél kisebb, részecskéi ma
már számos, részben közvetlen emberi expozícióval járó
alkalmazásban megjelentek. Ismert tulajdonságaik – nagy
fajlagos felület, szervezeten belüli mozgékonyság, oxidatív
stressz keltése, gyulladásmediátorok felszabadítása stb. –
alapján idegrendszeri károsodást okozhatnak, azonban erre
vonatkozóan csak kevés és ellentmondó adat áll rendelke-
zésre. Erre, és más fémoxid-nanorészecskékkel szerzett
tapasztalatokra alapozva a jelen munkában azt vizsgáltuk,
milyen általános és idegrendszeri toxikus hatás idézhetô elô
TiO2-nanorészecskék patkányok légutaiba való adagolásá-
val.
Anyagok és módszerek – Fiatal felnôtt hím Wistar-patká-
nyokat (öt csoport, 10-10 állat) kezeltünk naponta, 28
napig, 1% hidroxietil-cellulózt tartalmazó foszfátpufferelt fizi-
ológiás oldatban szuszpendált, körülbelül 10 nm átmérôjû
TiO2-nanorészecskék intratrachealis instillációjával, 1, 3 és
10 mg/ttkg dózisban. A vivôanyagos kontrollcsoport a
szuszpendáló közeget kapta instillálva, míg a kezeletlen
kontrollok semmit sem. A kezelés során naponta mértük a
testtömeget és megfigyeltük az állatok általános klinikai
állapotát. Az expozíciós periódust követôen uretánaltatás-
ban kérgi alapaktivitást, szenzoros kiváltott potenciálokat, és
a farokideg akciós potenciálját regisztráltuk; végül az álla-
tokat felboncoltuk és szövetmintákat vettünk fémszint-meg-
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Nano-titanium, more exactly particles of TiO2with typical size below 100 nm, has gained by
now a broad range of application, first of all as
white pigment; in paints and coatings but also in
food, personal care and pharmaceutical products1,
possibly leading to direct exposure of humans.
Primary production (yearly a few thousand tons
worldwide) and processing to final products
involves the risk of workplace exposure by inhala-
tion2; the actuality of the health risk is indicated by
the occupational exposure limit of 0.3 mg/m3 for
ultrafine (<100nm diameter) TiO2, set by National
Institute of Occupational safety and Health3.
On inhalation (the most typical way of exposure)
nanoparticles (NPs) are either deposited in the
nasopharynx or get down to the alveoli; then reach
distant body parts by migrating along the olfactory
and other nerves, or by crossing the alveolar and
capillary wall and entering systemic circulation.
The high surface-to-volume ratio of NPs results in
intense surface-dependent reactions, among others
generation of reactive oxygen species. NPs were
shown also to target mitochondria directly and dis-
rupt oxidative phosphorylation, also resulting in
ROS4.
Oxidative stress of any source can especially
affect the nervous system because of its high sensi-
tivity, due to highly active mitochondrial energy
production to cover the neurons’ energy demand, to
abundance of (unsaturated) structural lipids, and to
low antioxidant defence capacity5. The nervous sys-
tem consequences seen in animals treated experi-
mentally with TiO2 NPs have been up to now rather
variable. In some experiments, access of TiO2 NPs
to the rat brain after application to the airways was
verified, together with damage to the blood-brain
barrier6; the same authors also reported dose-and
time-dependent toxicity of the identical TiO2 NPs
on rat astrocytes in vitro. Others, however, found
that most of the nano-TiO2 remained in the lungs
7.
Functional alterations, possibly resulting from
access of TiO2 NPs to the brain, have been
described at the level of electrophysiological
changes only a few times up to now. Using murine
frontal cortex neuronal networks cultured in vitro,
uptake of nano-TiO2 by the cells and massive
depression of spike activity was found8. In mice, 60
days oral nano-TiO2 treatment caused neuronal
degeneration and dose-dependently reduced hip-
pocampal long-term potentiation in vivo9.
Human cultured neuronal (SH-SY5Y) and glial
(D384) cells also showed TiO2 NP internalization,
followed by mitochondrial and membrane dam-
age10; and neurological symptoms were detected in
humans exposed to airborne particles of a titanium-
based pigment at the workplace11.
Based on the multitude of applications of nano-
TiO2 mentioned above, and the experiences with
other metal oxide nanoparticles applied intratra-
cheally12, the aim of the present study was to inves-
tigate certain general and (electrophysiologically
detectable) neurotoxic effects of TiO2 NPs suspen-
sion applied in the airways of rats.
Methods
ANIMALS AND TREATMENT
Young adult male SPF Wistar rats (Crl:WIBr; 6
weeks old, 170±20 g body weight) were used,
obtained from Toxi-Coop Ltd. (Budapest, Hun -
Results – The two higher doses reduced the rate of body
weight gain significantly. Sensory evoked potentials and tail
nerve action potential were significantly slowed, but the
change in the spectrum of spontaneous cortical activity was
not significant. Correlation of moderate strength was found
between certain evoked potential parameters and brain Ti
level and oxidative stress data.
Conclusion – Our results underlined the possible neuroto-
xicity of TiO2 NPs but also the need for further investigati-
ons.
Keywords: nanoparticles, titanium dioxide, neurotoxicity,
oxidative stress
határozásra és az oxidatív stressz biokémiai indikátorainak
mérésére.
Eredmények – A két nagyobb dózisú csoportban a testtö-
meg-gyarapodás üteme szignifikánsan csökkent. A szenzo-
ros kiváltott potenciálok és a farokideg akciós potenciálja
szignifikánsan lassabbak lettek, a spontán kérgi aktivitás
spektrumának változása azonban nem mutatott szignifikáns
eltérést. A kiváltott potenciálok egyes paraméterei, illetve az
agykéreg titánszintje és oxidatívstressz-jellemzôje között
közepes mértékû korreláció mutatkozott.
Következtetés – Az eredmények rámutatnak a TiO2-nano-
részecskék lehetséges neurotoxicitására, de egyben a felté-
telezett hatásmechanizmus alátámasztása céljából végzen-
dô további vizsgálatok szükségességére is.
Kulcsszavak: nanorészecskék, titán-dioxid, neurotoxicitás,
oxidatív stressz
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gary). The total number of animals
was 50, sufficient for p=0.8 in
power analysis. The rats were
kept, two in a cage, in a GLP-rated
animal house (12-12 hour
light/dark cycle with light on at
06:00; temperature 22±3 °C, 30-
70% relative humidity); and could
consume unlimited amount (20-30
g/day/animal) of standard rodent
food (Ssniff R/M-Z+H, also from Toxi-Coop Ltd.,
Budapest, Hun gary) and water. After one week of
acclimation, the rats were randomized to 5 treat-
ment groups of 10 rats each, on the basis of their
body weight and spontaneous exploratory activity.
The groups and corresponding treatments are
shown in Table 1.
The TiO2 NPs used to treat the rats were synthe-
sized as follows: Titanium isopropoxide (TTIP;
7.32 g) was added to 50 ml ethanol (absolute) and
stirred for ten minutes. Simultaneously, 20 ml
ethanol was mixed in 165.5 ml distilled water and
stirred for the same duration. Then, the ethanol-
water mix was added dropwise (slowly: one drop
per 5 seconds) to the TTIP solution which was con-
tinuously stirred at high speed (1200 rpm), and stir-
ring was continued for 30 min after adding all the
ethanol-water mix. The TiO2 nanoparticles generat-
ed were collected from the suspension by centrifug-
ing and were dried for 36 hours at 80°C in air.
Diameter of the NPs produced, determined by
transmission electron microscopy, was ca. 10 nm.
The size histograms, in dry and freshly suspended
state, are given in Figure 1.
Treatment of the rats was done daily for 28 days
(five treatment days/week), always between 8:00
and 10:00 am. The TiO2 NPs were suspended to the
doses given in Table 1 in PBS (pH 7.4) with 1%
hydroxyethyl cellulose (efficient dispersion was
aided by sonication using a UP200HT instrument)
and were applied to the rats by intratracheal instil-
lation (1 ml/kg b. w. volume) in brief anesthesia
(see12 for details of the technique). Rats in the vehi-
cle control group (VC) underwent the same daily
procedure of anaesthesia and instillation while the
untreated controls (C) had nothing beyond daily
animal care.
Urethane and the chemicals for the NP synthesis
were from Sigma-Aldrich. Hydroxyethyl cellulose
was obtained at the pharmacy of the Medical Fa -
culty.
GENERAL TOXICOLOGICAL AND CHEMICAL MEASUREMENTS
The rats’ body weight was measured every morn-
ing, before treatment, to determine the exact daily
doses to be instilled and to see the effect on body
weight gain.
Table 1. Groups and treatment
Groups Code Treatment
Untreated control C –
Vehicle control VC PBS-HEC, 1 ml/kg b. w.
Treated, low dose LD TiO2 NPs in PBS-HEC, 1 mg/kg b. w.
Treated, medium dose MD TiO2 NPs in PBS-HEC, 3 mg/kg b. w.
Treated, high dose HD TiO2 NPs in PBS-HEC, 10 mg/kg b. w.
Figure 1. Particle size histograms of the TiO2 nanoparticles in dry (as-prepared, left graph) and freshly suspended
(right graph) state 
AD: average diameter; SD: standard deviation.
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After electrophysiological recording at the end
of the experiment, the rats were sacrificed by an
overdose of urethane (twice the anaesthetic dose
mentioned below) and were dissected. First, 2-3 ml
blood was taken from the abdominal vein of each
rat for Ti level and some ROS parameters measure-
ment. Three rats from each group, chosen random-
ly, were then transcardially perfused with 300 ml
saline of 4°C temperature to remove blood from
the organs, and were then dissected. The organs
heart, kidneys, adrenals, liver, lungs, spleen and
thymus were weighed, and relative organ weights
(to 1/100 body weight) were calculated. Brain,
liver and lung samples were stored at –20°C for Ti
level measurement. In another three rats per group,
also chosen randomly, dissection was done rapidly
right after sacrifice and blood taking. Having the
organs weighed, brain, liver and lung samples were
shock-frozen in liquid nitrogen and stored at –20°C
for subsequent measuring lipid peroxidation, as an
indicator of oxidative stress induced by the TiO2
NPs, using the thiobarbiturate reaction. Ti level
from the perfused rats’ samples was determined by
ICP-MS. For that, the samples were dried to con-
stant weight at 80°C, and were digested as follows:
3 ml cc. HCl/g wet tissue for 90 min at 90°C, then
an equal volume of cc. HNO3 was added and
digested for further 90 min. This procedure proved
to be necessary to reliably dissolve all TiO2. The
resulting liquid was filtered on 0.45 mm
hydrophilic membrane filter and diluted to 100 ml
final volume.
ELECTROPHYSIOLOGICAL RECORDING
Electrophysiological recording was done on the day
following the last TiO2 NP administration. In ure-
thane anaesthesia (1000 mg/kg ip.) the left hemi-
sphere was exposed by a sagittal cut in the head skin,
blunt removal of connective tissues, then drilling
around and removing the left parietal bone.
Following recovery (at least 30 min), recording elec-
trodes were placed on the primary somatosensory
(SS), visual (VIS) and auditory (AUD) areas. The
areas were identified by means of a somatotopic
map, and fine positioning of the electrodes was done
by searching for the punctum maximum of the
evoked responses. A stainless steel clamp, attached
to the cut skin edge, was used as indifferent elec-
trode. With the cortical electrode positions finalized,
electrocorticogram (ECoG) was recorded for 6 min.
Analysis of the ECoG records provided the power
spectrum based on standard human EEG bands.
Then, trains of sensory stimuli (SS: electric
shocks [3-4 V, 0.05 ms] to the contralateral whisker
pad, VIS: flashes [0.2 ms] from a high-luminance
white LED, AUD: clicks [70 dB] through the hol-
low ear bar of the stereotaxic frame) were applied,
and cortical evoked potentials (EPs) recorded from
the same sites. One train of 50 stimuli was given
with 1 Hz frequency. SS stimulation was repeated
with 2 and 10 Hz to see any frequency effect. On
the EPs, latency and duration of the main waves
was measured manually after averaging.
From the tail nerve, compound action potential
(CAP) was recorded by inserting a pair of needle
electrodes at the base of the tail for stimulation (3-
4 V, 0.05 ms shocks) and another pair 50 mm dis-
tally for recording. Conduction velocity was cal-
culated from this distance and the onset latency of
the CAP. Relative refractory period was measured
by double stimuli with inter-stimulus interval dec -
reased from 10 to 1 ms, based on the extra delay of
the second potential. From the data of the SS EPs
and the CAPs, it was possible to calculate the ratio
of identical parameters (latency or amplitude) of
the last and first five potentials from a series of 50,
and use this as an indicator of fatigue (as outlined
in13).
Stimulation, recording and analysis was done
using the NEUROSYS 1.11 software (Experimetria
Ltd., Budapest, Hungary). For further details of
electrophysiological recording and analysis, see13.
During the whole study, the principles of the
Ethical Committee for the Protection of Animals in
Research of the University were strictly followed.
The methods used in this work were licensed by the
authority competent in animal welfare issues under
No. XXI./151/2013.
DATA PROCESSING
From the individual rats’ data, group mean and
standard deviation was obtained. Depending on the
normality of data distribution, checked by Shapiro-
Wilk test. Body/organ weight data, of sufficiently
normal distribution, were analysed by one-way
ANOVA and post hoc Tukey test while for electro-
physiological and chemical-biochemical data non-
parametric Kruskal-Wallis ANOVA and post hoc
Mann-Whitney U-test was used, with p<0.05 as
limit of significance for both. The software used
was SPSS version 22.0 (IBM Corp., USA).
The possible linear correlation between data sets
was tested by the “linear fit” function of MS Excel.
This function uses the least squares method to fit a
straight line to the measurement data, and examines
the strength of relationship with Fisher’s F test. 
Results
EFFECT ON BODY AND ORGAN
WEIGHT GAIN
The effect of treating the
rats with TiO2 NPs on the
body weight gain is shown
in Figure 2. From the 3rd
week on, a significant
deficit in body weight gain
was observed in the
groups MD and HD, com-
pared to the untreated con-
trols (C). A clear differ-
ence was also present
between the weight gain of
the untreated (C) and vehi-
cle treated (VC) controls,
showing that the treatment
procedure itself had some effect, but that was not
significant. It is also of interest that the strongest
effect was seen with the medium, and not the high,
dose. In the overall weight gains (C: 213.65±34.98
g; VC: 177.38±43.39 g; LD: 187.66±37.19 g; MD:
142.15±16.49 g; HD: 165.16±26.61 g) also MD vs.
VC was significant at p<0.05.
The relative weight of the lungs was significant-
ly increased in the groups MD and HD, both vs. C
and VC (Table 2). The increase of the relative brain
and kidney weight was significant only vs. C.
Again, the effect of the medium dose was the
strongest. Other organ weights showed no marked
alteration.
ELECTROPHYSIOLOGICAL CHANGES
On the cortical EPs, lengthening of the latency was
observed in the treated rats, first of all with the two
higher doses. Significant lengthening of the SS EP
latency, vs. both C and VC (Figure 3) was seen in
group MD and HD. In these groups, also the fre-
quency-dependent extra lengthening of latency was
more marked than in LD and both controls. The
effect of nano-TiO2 exposure on the VIS and AUD
EPs was similar (Figure 2).
The [last 5 / first 5] ratio of the SS EP latency
(Figure 4) suggested increased fatigability of the
peripheral and central structures involved in the
generation of evoked potentials, and again showed
the non-monotonous dose dependence seen with
body weight gain and EP latency.
Conduction velocity of the tail nerve decreased
significantly in the MD and HD rats vs. C and VC
(Figure 5). Some increase of the relative refractory
period was seen but proved to be non-significant.
The [last 5 / first 5] ratio of the tail nerve CAP
latencies (Figure 6) was similar to that seen with
the SS EPs. The change in the ECoG spectrum, a
shift to higher frequencies in groups MD and HD
was, in contrast to the evoked activity forms,
insignificant (not shown).
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Figure 2. Time course of body weight in the control and treated rats over the weeks
of nano-Ti administration. The data shown were measured on Friday of each week 
Mean+SD, n=10. *, **: p<0.05, 0.01 vs. C.
Table 2. Relative organ weights (to 1/100 body weight) in the control and treated rats at the end of treatment 
Groups Relative organ weights
Brain Lungs Kidneys Liver
C 0.443±0.03 0.303±0.02 0.584±0.02 3.221±0.321
VC 0.483±0.06** 0.559±0.04*** 0.632±0.09*** 3.153±0.213
LD 0.508±0.07*** 0.565±0.09*** 0.691±0.09*** 3.180±0.183
MD 0.510±0.02*** 0.656±0.10***# 0.669±0.09**# 3.183±0.290
HD 0.498±0.04 0.642±0.06***# 0.640±0.07* 3.223±0.361
Mean+SD, n=10. *, **, ***: p<0.05, 0.01, 0.001 vs. C; #: p<0.01 vs. VC.
TISSUE METAL LEVELS AND BIOCHEMICAL ALTERATIONS
The measured levels of tissue Ti content and lipid
peroxidation are shown – only for groups with sig-
nificant electrophysiological effect, that is, in MD
and HD – in Table 3. Most of the Ti administered
to the rats remained in the lungs but there was a
measurable dose-dependent deposition of Ti also in
the brain mass, and, with less clarity, in the liver.
The low number of measured samples (see
Methods) mostly precluded the detection of signifi-
cant differences but the proportionality of inner Ti
levels and lipid peroxidation to the doses applied
was clear.
The relationship suggested by the data of inter-
nal Ti load, oxidative stress, and functional alter-
ations was tested by exam-
ining the possible linear
correlations. A seen in
Figure 7, correlation of
moderate strength was
found between the latency
of SS EP at 10 Hz stimula-
tion (exerting the maximal
strain on the somatosenso-
ry pathway in this experi-
mental scheme) and the
level of Ti and TBARS in
the brain samples (in case
of the latter, in spite of
apparent no-effect at
group level). The level of
correlation between VIS
EP latency and the same
chemical parameters was
similar (not shown).
Discussion
The results showed that
the doses and way of
application of TiO2 NPs to
rats, as performed in the
present experiment, were
effective in creating inter-
nal load and inducing
signs of general and nerv-
ous system toxicity. Ac -
cording to the measured
tissue Ti levels, most of
the amount applied re -
mained in the lungs but the
load measured in the brain
and other organ samples
was also considerably higher than in the rats with-
out nano-TiO2 exposure. The high degree of depo-
sition of TiO2 NPs in the lungs was in similar to the
observation in7 that a single amount instilled in the
trachea of rats was completely retained in the lungs
for 7 days.
The adequacy of the model is determined, how-
ever, also by the relationship of the experimentally
generated exposure to that described in exposed
humans and to the relevant limit values. There are
not many data available on occupational airborne Ti
exposure. Those published in14 show that in Europe
and North America there were no workplace levels
above 1 mg/m3 (for the whole respirable fraction) in
the last 20 years. Recommended exposure limits of
NIOSH3 from 2011 are 2.4 mg/m3 for suspended
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Figure 3. Latency of the somatosensory (upper graph) and visual and auditory (lower
graph) cortical evoked potentials 
Mean+SD, n=10.
*, **, ***: p<0.05, 0.01, 0.001 vs. C; #, ##: p<0.05, 0.01 vs. VC; °, °°, °°°: p<0.05, 0.01, 0.001 vs. 1 Hz
stimulation within the same group.
TiO2 dust and 0.3 mg/m
3
for ultrafine dust (that is,
for TiO2 NPs) in a 4×10
hours per week exposure
scheme. Calculating with
the daily ventilation vol-
ume of rats15, the dose of
TiO2 NP applied in the
rats’ trachea in the present
study would be equal to
atmospheric concentra-
tions of ca. 5, 15 and 50
mg/m3. These are about
one degree of magnitude
higher than the limit rec-
ommended by NIOSH, but
the length of exposure, 28
days, is a relatively short
fraction (ca. 1/30) of the
expectable life span of rats
and would thus corre-
spond to ca. 2.5 years in
humans (a relatively short
part of a job career).
Due to the tendency of
NPs to induce oxidative
stress in living organisms,
and the especial sensitivity
of the nervous system to
that (mentioned in
Introduction), ROS gener-
ation by TiO2 NPs in vari-
ous experimental settings
both in vitro and in vivo1 is
an important aspect of
possible CNS effects. In
vitro studies indicated
mitochondrial damage and
ROS generation on expo-
sure to TiO2 NPs in human
neuronal and glial cell
lines10. The tendency of
NPs to migrate to the
mitochondria and interfere
with oxidative phosphory-
lation4 might have contributed to that.
Oxidative damage to membrane lipids is likely
to result in changes of membrane fluidity and this
way in alterations of pulse propagation and synap-
tic transmission16. The causal chain from inner
exposure through oxidative stress up to functional
alteration was suggested by the results of the pres-
ent work in the relationship of SS EP latency and
the level of Ti and TBRAS in the brain (Figure 6).
The similar pattern of changes of EP latency and
tail nerve conduction velocity suggested that the
effect of TiO2 NPs on axonal conduction and synap-
tic transmission were both involved in the mecha-
nism of the observed changes. In8, spike rate in a
cultured neuronal network (including both neurons
and glial cells) decreased and the number of ROS-
positive cells increased in parallel. It was also
found, however, that neuronal activity was first
impaired at a much lower TiO2 NP dose than where
ROS production started to increase, suggesting con-
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Figure 4. Fatigue of the SS EPs during a series of 50 stimuli, quantified by the ratio
of the last and first EPs’ latencies (see Methods for details) 
Mean+SD, n=10.
*: p<0.05 vs. C.
Figure 5. Conduction velocity and relative refractory period of the tail nerve in the
control and treated rats 
Mean+SD, n=10.
***: p<0.001 vs. C; ###: p<0.001 vs. VC.
tribution of another, not
oxidative, mechanism
such as abnormal trans-
mitter turnover, i.e., im-
paired removal by glial
cells6 and/or disturbed
metabolism in the liver17.
The non-monotonous rela-
tionship, between cortical
and peripheral electro-
physiological changes and
brain TBARS levels on
one hand and applied TiO2
NP doses and measured
tissue Ti levels on the
other, was a peculiar phe-
nomenon. Its possible
background was that TiO2
NPs in the HD treatment
suspension had, in spite of
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Figure 6. Fatigue of the tail nerve action potential during a series of 50 stimuli,
quantified by the ratio of the last and first CAPs’ latencies (see Methods for details) 
Mean+SD, n=10.
#: p<0.05 vs. VC.
Table 3. Results of Ti level and TBARS determinations in the tissue samples from 3 randomly chosen rats per group
of groups VC, MD and HD
Measured Tissue Groups
parameters sample VC MD HD
Tissue Ti level brain 1739.58±639.05 3703.62±1161.03 4785.98±1316.65
(µg/kg) liver 651.30±568.52 771.78±91.90 2267.24±631.31#
lungs 353.96±611.34 492642.37±214699.00## 551847.60±65797.20##
TBARS reaction brain 13.68±0.85 14.72±1.56 13.73±0.20
(nM MDA/ liver 16.22±1.48 24.11±1.58 25.49±5.88
mg tissue) lungs 34.62±6.61 46.40±7.80 49.72±2.96
#: p<0.05; ##: p<0.01 vs. VC, n=3.
Figure 7. Correlation diagrams showing the strength of relationship of SS EP latency obtained with 10 Hz stimula-
tion to brain Ti levels (left graph) and brain lipid peroxidation (right graph). Each point represents the data pairs of
one animal (diamonds, VC; grey squares, MD, black squares, HD)
the stabilizing agent HEC and sonication, an
increased tendency to aggregate, resulting in
decreased relative surface, diminishing both surface
reactions and dissolution of ionic Ti.
Lipid peroxidation was considerable in both
brain and liver samples of the treated rats (Table 3)
but, as judged from the relative organ weights
(Table 2), the resulting damage in these organs was
not gross. In the liver, however, the turnover of
monoaminergic transmitters could be disturbed, as
mentioned in17, possibly contributing to the neuro-
functional alterations. The metabolic disturbance
suggested by increased presence of free radicals in
the liver could also provide explanation of the
reduced body weight gain seen in groups MD and
HD of the treated rats18. Increased relative kidney
weight (Table 2) was another indication of sys-
temic effect of TiO2 NPs and (as stated in
1) ROS-
induced damage.
The results of the present study underlined the
possible neurotoxicity of TiO2 NPs, but left some
questions open. The possible role of Ti dissolved
from the NPs, as well as the histological changes
possibly evolving in parallel to the observed neuro-
functional and biochemical ones, need further
investigations.
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